Table 3.
Variable | N | %Alive | 3-Yr Survival Rate (95%CI) | 5-Yr Survival Rate (95%CI) | Hazard Ratio | p-value |
---|---|---|---|---|---|---|
All | 1411 | 92.90% | 93.5%(91.5~95.1%) | 87.4%(84.3~89.9%) | ||
| ||||||
1988 Stage I (N=1307) | ||||||
IA | 570 | 96.80% | 97.7%(95.1~99%) | 92.4%(86.8~95.7%) | Ref. Level | <0.001 |
IB | 593 | 90.70% | 92.4%(89.1~94.7%) | 87.3%(82.9~90.6%) | 2.21(1.3~3.76) | |
IC | 144 | 87.50% | 88.4%(78.8~93.9%) | 75.7%(62.8~84.7%) | 3.54(1.84~6.82) | |
| ||||||
2009 Stage I (N=1411) | ||||||
IA | 1249 | 93.70% | 94.5%(92.5~96%) | 89.2%(86.1~91.7%) | Ref. Level | 0.001 |
IB | 162 | 87% | 86.8%(77.7~92.4%) | 75.1%(63.1~83.7%) | 2.19(1.35~3.56) | |
| ||||||
For 1988 IIA cohort (N=40)* | ||||||
2009 IA | 29 | 96.60% | 93.3%(61.3~99%) | 93.3%(61.3~99%) | ||
2009 IB | 11 | 81.80% | 66.7%(16~91.4%) | 66.7%(16~91.4%) | ||
| ||||||
For 1988 IIIA cohort (N=105)** | ||||||
2009 IA | 57 | 91.20% | 89.7%(64~97.4%) | 75.3%(45.3~90.3%) | ||
2009 IB | 7 | 85.70% | 75%(12.8~96.1%) | 75%(12.8~96.1%) | ||
2009>=II | 41 | 82.90% | 89.2%(73.6~95.8%) | 74.4%(52~87.5%) |
The results show if there is any heterogeneity among 1988 IIA cohort stratified by 2009 criteria
The results show if there is any heterogeneity among 1988 IIIA cohort stratified by 2009 criteria